TWO TOWER PLACE, SOUTH SAN FRANCISCO, CA
Announces Pricing of $175 Million in Equity Financings
Assembly Biosciences Shows Positive Results in ABI-5366 Study for Genital Herpes
Financial Results, Other Events
Other Events
Changes in Board, Management or Compensation, Shareholder votes
Reports First Quarter 2025 Financial Results and Recent Updates
Annual Report to Security Holders
Reports Year End 2024 Financial Results and Recent Highlights
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Additional Securities
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership